To scroll text in this page

Global Navigation
Global Navigation end

About Astellas

Start of the main text

2012 News Releases

About RSS

FDA Advisory Committee Recommends Approval of Mirabegron - Investigational Overactive Bladder Treatment from Astellas (pdf 51KB)

April 6, 2012

Printer-friendly version

Main Text end
Local Navigation
Local Navigation end
Related Links